| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | X8SPJ492VF |
| InChI Key | WKDNQONLGXOZRG-HRNNMHKYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C26H28N4O |
| Molecular Weight | 412.54 |
| AlogP | 4.24 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 72.86 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 31.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Beta-secretase 1 inhibitor | PubMed |
| Primary Target | |
|---|---|
| beta-secretase 1 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Aspartic protease
Aspartic protease AA clan
Aspartic protease A1A subfamily
|
- | - | - | 26 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Alzheimer Disease | 3 | D000544 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Renal Insufficiency | 1 | D051437 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1383982-64-6 |
| ChEMBL | CHEMBL3989948 |
| DrugBank | DB14814 |
| FDA SRS | X8SPJ492VF |
| Guide to Pharmacology | 7789 |
| PubChem | 67979346 |
| SureChEMBL | SCHEMBL9947930 |